Beijing Hotgen Biotech Co., Ltd (688068.SH) has cumulatively repurchased 0.98% of its shares, spending 150 million yuan.
Reconova Technologies (688068.SH) announced that as of January 31, 2026, the company has repurchased a total of 904,000 shares through a special securities account for share repurchases using the centralized bidding trading method, accounting for 0.98% of the total share capital of the company. The highest price for the repurchase transactions was 176.79 yuan per share, the lowest price was 145.59 yuan per share, and the total amount paid was 150 million yuan (excluding stamp duty, transaction commissions, and other transaction fees).
Beijing Hotgen Biotech Co., Ltd. (688068.SH) announced that as of January 31, 2026, the company has repurchased a total of 904,000 shares through a special securities account for stock repurchases, accounting for 0.98% of the total share capital of the company, through centralized auction trading. The highest price at which shares were repurchased was 176.79 yuan per share, and the lowest price was 145.59 yuan per share. The total amount paid for the repurchases was 150 million yuan (excluding stamp duty, transaction commissions, and other trading fees).
Related Articles

Yum China (09987) spent 773.98 million Hong Kong dollars to repurchase 20,100 shares on February 2nd.

As of the end of January, Lens Technology (06613) has repurchased approximately 7.4096 million A-shares.

Shanxi Install (02520) and Shanghai Jingyu have reached a joint venture agreement with Shanxi Infrastructure to establish a joint venture company to invest in a BOO project.
Yum China (09987) spent 773.98 million Hong Kong dollars to repurchase 20,100 shares on February 2nd.

As of the end of January, Lens Technology (06613) has repurchased approximately 7.4096 million A-shares.

Shanxi Install (02520) and Shanghai Jingyu have reached a joint venture agreement with Shanxi Infrastructure to establish a joint venture company to invest in a BOO project.

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


